Literature DB >> 29030495

Intracavitary ultrasound (ICARUS): a neuroendoscopic adaptation of intravascular ultrasound for intracerebral hemorrhage evacuation.

Alexander G Chartrain1, Danny Hom1, Joshua B Bederson1, J Mocco1, Christopher Paul Kellner1.   

Abstract

Neurosurgeons performing intracerebral hemorrhage evacuation procedures have limited options for monitoring hematoma evacuation and assessing residual hematoma burden intraoperatively. Here, we report the successful neuroendoscopic adaptation of intravascular ultrasound, referred to here as intracavitary ultrasound (ICARUS), in two patients. Pre-evacuation ICARUS demonstrated dense hematomas in both patients. Post-evacuation ICARUS in patient 1 demonstrated significant reduction in clot burden and two focal hyperechoic regions consistent with pockets of hematoma not previously seen with the endoscope or burr hole ultrasound. These areas were directly targeted and resected with the endoscope and suction device. Post-evacuation ICARUS in patient 2 showed significant reduction of hematoma volume without indication of residual blood. ICARUS findings were confirmed on intraoperative DynaCT and postoperative CT 24 hours later. ICARUS is feasibly performed in a hematoma cavity both before and after hematoma aspiration. ICARUS may provide additional information to the operating surgeon and assist in maximizing hematoma removal. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  endoscopy; hemorrhage; ultrasound

Mesh:

Year:  2017        PMID: 29030495      PMCID: PMC5652362          DOI: 10.1136/bcr-2017-013188

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

Review 1.  Contemporary clinical applications of coronary intravascular ultrasound.

Authors:  Michael C McDaniel; Parham Eshtehardi; Fadi J Sawaya; John S Douglas; Habib Samady
Journal:  JACC Cardiovasc Interv       Date:  2011-11       Impact factor: 11.195

2.  Real-time ultrasound-guided endoscopic surgery for putaminal hemorrhage.

Authors:  Hirokazu Sadahiro; Sadahiro Nomura; Hisaharu Goto; Kazutaka Sugimoto; Akinori Inamura; Yuichi Fujiyama; Akiko Yamane; Takayuki Oku; Mizuya Shinoyama; Michiyasu Suzuki
Journal:  J Neurosurg       Date:  2015-06-05       Impact factor: 5.115

Review 3.  Intravascular ultrasound in the evaluation and management of cerebral venous disease.

Authors:  Maxim Mokin; Peter Kan; Adib A Abla; Tareq Kass-Hout; Kenneth V Snyder; Elad I Levy; Adnan H Siddiqui
Journal:  World Neurosurg       Date:  2012-04-05       Impact factor: 2.104

Review 4.  A Review of Intravascular Ultrasound-based Multimodal Intravascular Imaging: The Synergistic Approach to Characterizing Vulnerable Plaques.

Authors:  Teng Ma; Bill Zhou; Tzung K Hsiai; K Kirk Shung
Journal:  Ultrason Imaging       Date:  2015-09-22       Impact factor: 1.578

5.  Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema.

Authors:  W Andrew Mould; J Ricardo Carhuapoma; John Muschelli; Karen Lane; Timothy C Morgan; Nichol A McBee; Amanda J Bistran-Hall; Natalie L Ullman; Paul Vespa; Neil A Martin; Issam Awad; Mario Zuccarello; Daniel F Hanley
Journal:  Stroke       Date:  2013-02-07       Impact factor: 7.914

6.  Intravascular ultrasonography-guided stent angioplasty of an extracranial vertebral artery dissection.

Authors:  Won-Ki Yoon; Young-Woo Kim; Sang-Don Kim; Ik-Seong Park; Min-Woo Baik; Seong-Rim Kim
Journal:  J Neurosurg       Date:  2008-12       Impact factor: 5.115

Review 7.  Modern intraoperative imaging modalities for the vascular neurosurgeon treating intracerebral hemorrhage.

Authors:  Oded Goren; Stephen J Monteith; Moshe Hadani; Mati Bakon; Sagi Harnof
Journal:  Neurosurg Focus       Date:  2013-05       Impact factor: 4.047

8.  Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial.

Authors:  Daniel F Hanley; Richard E Thompson; John Muschelli; Michael Rosenblum; Nichol McBee; Karen Lane; Amanda J Bistran-Hall; Steven W Mayo; Penelope Keyl; Dheeraj Gandhi; Tim C Morgan; Natalie Ullman; W Andrew Mould; J Ricardo Carhuapoma; Carlos Kase; Wendy Ziai; Carol B Thompson; Gayane Yenokyan; Emily Huang; William C Broaddus; R Scott Graham; E Francois Aldrich; Robert Dodd; Cristanne Wijman; Jean-Louis Caron; Judy Huang; Paul Camarata; A David Mendelow; Barbara Gregson; Scott Janis; Paul Vespa; Neil Martin; Issam Awad; Mario Zuccarello
Journal:  Lancet Neurol       Date:  2016-10-11       Impact factor: 44.182

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.